Projects per year
Organisation profile
Organisation profile
Department of Pathology established in Aug. 1961. The first department director was Prof. Ting-Yao Chen. Prof. Chen constructed the pathology teaching system for students of medicine, phamacology, medical technology, and nursing since. Aug. 1962. The pathology department also provided pathology services for hospital in addition to teaching for the college. After the retirement of Prof. Chen in 1997, Prof. Huang became the director of the department.
Fingerprint
Dive into the research topics where Department of Pathology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
I-Wei Chang
- Department of Pathology - Associate Professor
- Taipei Medical University Shuang Ho Hospital - Visiting Staff
Person: Researcher
-
Wei-Chin Chang
- Department of Pathology - Assistant Professor
- Taipei Medical University Hospital - Visiting Staff
Person: Researcher
-
Bo-Jung Chen
- Department of Pathology - Assistant Professor
- Taipei Medical University Shuang Ho Hospital - Visiting Staff
Person: Researcher
-
運用中孔洞二氧化矽奈米載體傳遞PBX1抑制劑克服吉西他濱所誘導抗藥性胰臟癌之癌幹細胞特性
Shen, Y.-A. (PI)
1/1/26 → 12/31/26
Project: A - Government Institution › a - National Health Research Institutes
-
教育部跨域彈性修業試辦計畫夥伴學校計畫
Chu, J.-S. (PI)
1/1/26 → 12/31/26
Project: A - Government Institution › d - Ministry of Education
-
Utilizing Glucosamine-Labeled Nanodrugs as a Novel Pancreatic Cancer Stem Cell Therapy to Counteract Metabolic Compensation and Synergistically Inhibit Transcriptional Activity( II )
Shen, Y.-A. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
Research output
-
A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancer
Dung, P. V. T., Chen, W. Y., Liu, M. K., Yeh, S. D., Kajla, G., Yeh, H. L., Chen, W. H., Jiang, K. C., Li, H. R., Chen, C. S., Beltran, H., Wen, Y. C. & Liu, Y. N., Jan 2026, In: Neoplasia (United States). 71, 101251.Research output: Contribution to journal › Article › peer-review
Open Access -
Analysis of the Yield of Intestinal Metaplasia Based on Biopsy Numbers and Follow-Up Endoscopy in a Large Series of Asian Patients With Barrett's Esophagus
Tsai, Y. N., Chang, C. Y., Chen, C. C., Lee, C. T., Hsu, M. H., Chang, I. W., Lin, J. T., Wang, H. P., Moi, S. H. & Wang, W. L., Jan 2026, In: Digestive Endoscopy. 38, 1, e70077.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Critical radiosensitizing parameters of dual-modality gold nanodandelion against cancer radioresistance in MV X-ray and proton therapies
Chuang, Y. C., Chiou, J. F., Wu, P. H., Shen, Y. A., Chang, W. M., Hsia, Y., Kuo, C. C., Wang, W. J., Lo, L. W. & Lee, H. L., Jun 2026, In: Materials Today Advances. 30, 100757.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
Dataset
-
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y.-C. (Contributor), Zeng, T. (Creator), Abou-Kheir, W. (Creator), Yeh, H.-L. (Contributor), Yin, J. J. (Creator), Lee, Y.-C. (Creator), Chen, W.-Y. (Creator) & Liu, Y.-N. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4008787.v1, https://doi.org/10.6084%2Fm9.figshare.c.4008787.v1
Dataset
-
Supplementary Material for: The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme
Lee, P.-Y. (Creator), Chen, C.-L. (Creator), Lin, Z.-Z. (Creator), Cheng, A.-L. (Creator), Chen, E.I.-T. (Creator), Whang-Peng, J. (Creator) & Huang, C.-Y. F. (Contributor), Karger Publishers, 2013
DOI: 10.6084/m9.figshare.5124601.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_The_Aurora_Kinases_Inhibitor_VE-465_is_a_Novel_Treatment_for_Glioblastoma_Multiforme/5124601/1
Dataset